Discovery of a Potent Proteolysis Targeting Chimera Enables Targeting the Scaffolding Functions of FK506‐Binding Protein 51 (FKBP51)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Angewandte Chemie International Edition, 63, (3), Wiley-VCH, ISSN 1433-7851
- Ereignis
-
Veröffentlichung
- (wo)
-
Darmstadt
- (wer)
-
Universitäts- und Landesbibliothek
- (wann)
-
2024
- Urheber
-
Geiger, Thomas M.
Walz, Michael
Meyners, Christian
Kuehn, Angela
Dreizler, Johannes
Sugiarto, Wisely O.
Maciel, Edvaldo V. S.
Zheng, Min
Lermyte, Frederik
Hausch, Felix
- DOI
-
10.26083/tuprints-00027257
- URN
-
urn:nbn:de:tuda-tuprints-272575
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Geiger, Thomas M.
- Walz, Michael
- Meyners, Christian
- Kuehn, Angela
- Dreizler, Johannes
- Sugiarto, Wisely O.
- Maciel, Edvaldo V. S.
- Zheng, Min
- Lermyte, Frederik
- Hausch, Felix
- Universitäts- und Landesbibliothek
Entstanden
- 2024
Ähnliche Objekte (12)
Discovery of a Potent Proteolysis Targeting Chimera Enables Targeting the Scaffolding Functions of FK506‐Binding Protein 51 (FKBP51)
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors
Development of the first selective proteolysis targeting chimera for the FK506-binding protein 51
Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera
A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells
Proteolysis targeting chimeras (PROTACs) for epigenetics research
Targeting proteolysis in viral cardiac inflammatory disease
Proteolysis targeting chimeras (PROTACs) in cancer therapy
Proteolysis-targeting chimeras (PROTACs) in cancer therapy
Discovery of a Potent Proteolysis Targeting Chimera Enables Targeting the Scaffolding Functions of FK506‐Binding Protein 51 (FKBP51)
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors
Development of the first selective proteolysis targeting chimera for the FK506-binding protein 51
Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera
A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells
Proteolysis targeting chimeras (PROTACs) for epigenetics research
Targeting proteolysis in viral cardiac inflammatory disease
Proteolysis targeting chimeras (PROTACs) in cancer therapy
Proteolysis-targeting chimeras (PROTACs) in cancer therapy
Discovery of a Potent Proteolysis Targeting Chimera Enables Targeting the Scaffolding Functions of FK506‐Binding Protein 51 (FKBP51)
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors
Development of the first selective proteolysis targeting chimera for the FK506-binding protein 51
Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera
A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells
Proteolysis targeting chimeras (PROTACs) for epigenetics research
Targeting proteolysis in viral cardiac inflammatory disease
Proteolysis targeting chimeras (PROTACs) in cancer therapy